谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Preclinical Characterization of LY3962673, an Orally Bioavailable, Highly Potent, and Selective KRAS G12D Inhibitor

Chandrasekar Iyer,Binghui Li,Trent R. Stewart, Tao Wang,Andrew Capen, Rachel Cavitt,Bryan D. Anderson,Wayne Bocchinfuso,Gaiying Zhao,Michael J. Rodriguez, Santiago Carballares,Andrew Cooke,Robert Bondi,Lee Burns, Lakshmi Kelamangalath,Ross Wallace, Gabrielle Kolakowski,James R. Henry,Chong Si

MOLECULAR CANCER THERAPEUTICS（2023）

引用 0|浏览1
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要